HCA Healthcare Inc (NYSE:HCA) shares hit a new 52-week high during mid-day trading on Friday after Morgan Stanley raised their price target on the stock from $105.00 to $115.00. Morgan Stanley currently has an underweight rating on the stock. HCA Healthcare traded as high as $131.69 and last traded at $131.03, with a volume of 35058 shares changing hands. The stock had previously closed at $129.19.

Several other research firms have also commented on HCA. Credit Suisse Group increased their price target on shares of HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research report on Friday, July 27th. ValuEngine lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, June 28th. SunTrust Banks reiterated a “buy” rating and issued a $125.00 price target on shares of HCA Healthcare in a research report on Friday, July 20th. Jefferies Financial Group reiterated a “buy” rating and issued a $135.00 price target on shares of HCA Healthcare in a research report on Thursday, July 26th. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research report on Monday, July 16th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Buy” and an average price target of $119.76.

In related news, SVP Deborah M. Reiner sold 1,204 shares of the firm’s stock in a transaction that occurred on Tuesday, June 5th. The shares were sold at an average price of $105.00, for a total transaction of $126,420.00. Following the sale, the senior vice president now owns 3,432 shares in the company, valued at $360,360. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Victor L. Campbell sold 22,782 shares of the firm’s stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $127.12, for a total transaction of $2,896,047.84. Following the sale, the senior vice president now owns 202,650 shares in the company, valued at approximately $25,760,868. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 204,168 shares of company stock worth $24,581,821. 2.80% of the stock is owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Smithfield Trust Co. boosted its position in HCA Healthcare by 541.9% during the second quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after acquiring an additional 840 shares during the last quarter. Summit Trail Advisors LLC boosted its holdings in shares of HCA Healthcare by 9,933.3% in the 1st quarter. Summit Trail Advisors LLC now owns 112,774 shares of the company’s stock valued at $113,000 after purchasing an additional 111,650 shares during the last quarter. Signet Financial Management LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $137,000. Adviser Investments LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $159,000. Finally, Bridgeworth LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $173,000. Hedge funds and other institutional investors own 71.84% of the company’s stock.

The firm has a market cap of $44.35 billion, a price-to-earnings ratio of 19.78, a price-to-earnings-growth ratio of 1.16 and a beta of 0.53. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of -7.64.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.16 by $0.13. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The company had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same quarter last year, the business earned $1.73 EPS. HCA Healthcare’s revenue for the quarter was up 7.4% on a year-over-year basis. research analysts expect that HCA Healthcare Inc will post 9.23 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Stockholders of record on Tuesday, September 4th will be paid a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend is Friday, August 31st. HCA Healthcare’s dividend payout ratio is presently 21.24%.

HCA Healthcare Company Profile (NYSE:HCA)

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Trading Strategy Methods and Types

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.